SlideShare a Scribd company logo
1 of 20
Meta-regression with DisMod-MR:
how robust is the model?
June 18, 2013
Hannah M Peterson
Post-Bachelor Fellow
Global Burden of Disease Study 2010
2
YLDs
β€’ Measures morbidity
β€’ Requires age-specific prevalence
o For 291 outcomes
o For 2 sexes
o For 187 countries
o For 3 years
3
Is negative-binomial distribution
the best choice?
DisMod-MR
4
Alternative distributions
5
Distribution Probability Density Function
Normal
Lognormal
Binomial
Negative-
binomial
Alternative distributions
6
Distribution Probability Density Function
Normal
Lognormal
Binomial
Negative-
binomial
Alternative distributions
7
Distribution Probability Density Function
Normal
Lognormal
Binomial
Negative-
binomial
Alternative distributions
8
Distribution Probability Density Function
Normal
Lognormal
Binomial
Negative-
binomial
Potential experimental frameworks
β€’ Data collection
o Ideal
o Impractical
β€’ Simulation
o Impossible to know true data distribution
β€’ Out-of-sample cross validation
o Do not have to choose distribution
9
Out-of-sample cross validation
10
Out-of-sample predictive validity
β€’ Randomly select 25% of
data to use as β€œtest data”
11
Out-of-sample predictive validity
β€’ Randomly select 25% of
data to use as β€œtest data”
12
Out-of-sample predictive validity
β€’ Randomly select 25% of
data to use as β€œtest data”
β€’ Fit the remaining 75% of
data (β€œtraining data”)
13
Out-of-sample predictive validity
β€’ Randomly select 25% of
data to use as β€œtest data”
β€’ Fit the remaining 75% of
data (β€œtraining data”)
β€’ Use fit to calculate statistics
for test data
14
Out-of-sample predictive validity
β€’ Randomly select 25% of
data to use as β€œtest data”
β€’ Fit the remaining 75% of
data (β€œtraining data”)
β€’ Use fit to calculate statistics
for test data
β€’ For each distribution
β€’ For 1000 test-train splits
β€’ For each disease data set
15
Comparing distributions
16
How to determine the best distribution?
Metrics of evaluation
β€’
17
Results
18
Percent of wins (%)
Distribution Bias MAE PC Total
Normal 22.1 20.6 34.6 25.7
Lognormal 29.7 13.0 36.5 26.4
Binomial 26.3 48.3 1.9 25.5
Negative-
binomial
21.9 18.1 27.1 22.4
Conclusions
β€’ Choice of distribution doesn’t greatly influence results
β€’ Best overall performance: lognormal distribution
o Contingent on method to adjust data whose value is 0
β€’ Further investigate when each distribution performs best
o Dependent on number of covariates, priors, amount of data?
19
Thank you
Hannah Peterson
peterhm@uw.edu
www.healthmetricsandevaluation.org

More Related Content

What's hot

Longitudinal Design and its Types
Longitudinal Design and its TypesLongitudinal Design and its Types
Longitudinal Design and its TypesMuhammad Rawaha Saleem
Β 
Types of Research
Types of ResearchTypes of Research
Types of ResearchNeha Bansal
Β 
Multivariate Analysis Techniques
Multivariate Analysis TechniquesMultivariate Analysis Techniques
Multivariate Analysis TechniquesMehul Gondaliya
Β 
Chi square test and its types
Chi square test and its typesChi square test and its types
Chi square test and its typesRizwan S A
Β 
Research Methods
Research MethodsResearch Methods
Research MethodsDJ CrissCross
Β 
Longitudinal Research Design
Longitudinal Research DesignLongitudinal Research Design
Longitudinal Research DesignShantaRayamajhiBasne
Β 
Research data collection methods and tools
Research data collection methods and toolsResearch data collection methods and tools
Research data collection methods and toolsLikhila Abraham
Β 
Descriptive Research
Descriptive  ResearchDescriptive  Research
Descriptive ResearchAmenahGondal1
Β 
Ethnographic studies by hina kaynat
Ethnographic studies by hina kaynatEthnographic studies by hina kaynat
Ethnographic studies by hina kaynatDr. Hina Kaynat
Β 
Qualitative Research Methods for Public Health
Qualitative Research Methods for Public HealthQualitative Research Methods for Public Health
Qualitative Research Methods for Public HealthCelia Emmelhainz
Β 
Observation In Research
Observation In ResearchObservation In Research
Observation In ResearchMarites Hugo
Β 
4. scientific methods of research
4.  scientific methods of research4.  scientific methods of research
4. scientific methods of researchChanda Jabeen
Β 
Research Methodology
Research MethodologyResearch Methodology
Research Methodologynithruja
Β 
Lesson 5 research objectives
Lesson 5 research objectivesLesson 5 research objectives
Lesson 5 research objectivesDr. P.B.Dharmasena
Β 
3. Reviewing the literature
3. Reviewing the literature3. Reviewing the literature
3. Reviewing the literatureRazif Shahril
Β 
Qualitative research, types, data collection and analysis
Qualitative research, types, data collection and analysisQualitative research, types, data collection and analysis
Qualitative research, types, data collection and analysisVijayalakshmi Murugesan
Β 
Research Methodology study method
Research Methodology study methodResearch Methodology study method
Research Methodology study methodMayur Khatri
Β 

What's hot (20)

Longitudinal Design and its Types
Longitudinal Design and its TypesLongitudinal Design and its Types
Longitudinal Design and its Types
Β 
Survey research
Survey  researchSurvey  research
Survey research
Β 
Types of Research
Types of ResearchTypes of Research
Types of Research
Β 
Multivariate Analysis Techniques
Multivariate Analysis TechniquesMultivariate Analysis Techniques
Multivariate Analysis Techniques
Β 
Chi square test and its types
Chi square test and its typesChi square test and its types
Chi square test and its types
Β 
Research Methods
Research MethodsResearch Methods
Research Methods
Β 
Longitudinal Research Design
Longitudinal Research DesignLongitudinal Research Design
Longitudinal Research Design
Β 
Research data collection methods and tools
Research data collection methods and toolsResearch data collection methods and tools
Research data collection methods and tools
Β 
Descriptive Research
Descriptive  ResearchDescriptive  Research
Descriptive Research
Β 
Ethnographic studies by hina kaynat
Ethnographic studies by hina kaynatEthnographic studies by hina kaynat
Ethnographic studies by hina kaynat
Β 
Qualitative Research Methods for Public Health
Qualitative Research Methods for Public HealthQualitative Research Methods for Public Health
Qualitative Research Methods for Public Health
Β 
Observation In Research
Observation In ResearchObservation In Research
Observation In Research
Β 
Ethnography research
Ethnography researchEthnography research
Ethnography research
Β 
4. scientific methods of research
4.  scientific methods of research4.  scientific methods of research
4. scientific methods of research
Β 
Research Methodology
Research MethodologyResearch Methodology
Research Methodology
Β 
Lesson 5 research objectives
Lesson 5 research objectivesLesson 5 research objectives
Lesson 5 research objectives
Β 
Research question
Research questionResearch question
Research question
Β 
3. Reviewing the literature
3. Reviewing the literature3. Reviewing the literature
3. Reviewing the literature
Β 
Qualitative research, types, data collection and analysis
Qualitative research, types, data collection and analysisQualitative research, types, data collection and analysis
Qualitative research, types, data collection and analysis
Β 
Research Methodology study method
Research Methodology study methodResearch Methodology study method
Research Methodology study method
Β 

More from Institute for Health Metrics and Evaluation - University of Washington

More from Institute for Health Metrics and Evaluation - University of Washington (20)

Salud Mesoamerica Initiative: Mixed-Methods Evaluation Plan
Salud Mesoamerica Initiative: Mixed-Methods Evaluation PlanSalud Mesoamerica Initiative: Mixed-Methods Evaluation Plan
Salud Mesoamerica Initiative: Mixed-Methods Evaluation Plan
Β 
Salud Mesoamerica Initiative: Select results from the third operation measure...
Salud Mesoamerica Initiative: Select results from the third operation measure...Salud Mesoamerica Initiative: Select results from the third operation measure...
Salud Mesoamerica Initiative: Select results from the third operation measure...
Β 
Salud Mesoamerica Process Evaluation: Evidence on Culture Change in Health Sy...
Salud Mesoamerica Process Evaluation: Evidence on Culture Change in Health Sy...Salud Mesoamerica Process Evaluation: Evidence on Culture Change in Health Sy...
Salud Mesoamerica Process Evaluation: Evidence on Culture Change in Health Sy...
Β 
Salud MesoamΓ©rica Initiative: Mixed-Methods Evaluation Plan
Salud MesoamΓ©rica Initiative: Mixed-Methods Evaluation PlanSalud MesoamΓ©rica Initiative: Mixed-Methods Evaluation Plan
Salud MesoamΓ©rica Initiative: Mixed-Methods Evaluation Plan
Β 
Salud Mesoamerica Initiative: Select results from the second operation measur...
Salud Mesoamerica Initiative: Select results from the second operation measur...Salud Mesoamerica Initiative: Select results from the second operation measur...
Salud Mesoamerica Initiative: Select results from the second operation measur...
Β 
Salud MesoamΓ©rica Initiative: Select results from the baseline measurement
Salud MesoamΓ©rica Initiative: Select results from the baseline measurementSalud MesoamΓ©rica Initiative: Select results from the baseline measurement
Salud MesoamΓ©rica Initiative: Select results from the baseline measurement
Β 
Quality of under-5 mortality statistics in YucatΓ‘n, Mexico (Spanish)
Quality of under-5 mortality statistics in YucatΓ‘n, Mexico (Spanish)Quality of under-5 mortality statistics in YucatΓ‘n, Mexico (Spanish)
Quality of under-5 mortality statistics in YucatΓ‘n, Mexico (Spanish)
Β 
Under-5 mortality and healthcare in YucatΓ‘n – 2017 Results dissemination work...
Under-5 mortality and healthcare in YucatΓ‘n – 2017 Results dissemination work...Under-5 mortality and healthcare in YucatΓ‘n – 2017 Results dissemination work...
Under-5 mortality and healthcare in YucatΓ‘n – 2017 Results dissemination work...
Β 
Under-5 mortality and healthcare in YucatΓ‘n – 2021 Results dissemination work...
Under-5 mortality and healthcare in YucatΓ‘n – 2021 Results dissemination work...Under-5 mortality and healthcare in YucatΓ‘n – 2021 Results dissemination work...
Under-5 mortality and healthcare in YucatΓ‘n – 2021 Results dissemination work...
Β 
The Global Fund Prospective Country Evaluation
The Global Fund Prospective Country EvaluationThe Global Fund Prospective Country Evaluation
The Global Fund Prospective Country Evaluation
Β 
Prospective Country Evaluation 2019 Synthesis Findings
Prospective Country Evaluation 2019 Synthesis FindingsProspective Country Evaluation 2019 Synthesis Findings
Prospective Country Evaluation 2019 Synthesis Findings
Β 
Global Burden of Disease (GBD) 2017 study findings
Global Burden of Disease (GBD) 2017 study findingsGlobal Burden of Disease (GBD) 2017 study findings
Global Burden of Disease (GBD) 2017 study findings
Β 
Expected Human Capital: Key themes and talking points
Expected Human Capital: Key themes and talking pointsExpected Human Capital: Key themes and talking points
Expected Human Capital: Key themes and talking points
Β 
Global Health Financing
Global Health FinancingGlobal Health Financing
Global Health Financing
Β 
Maternal and Child Mortality in the United States
Maternal and Child Mortality in the United StatesMaternal and Child Mortality in the United States
Maternal and Child Mortality in the United States
Β 
Salud MesoamΓ©rica 2015 Initiative: Select results from the first operation me...
Salud MesoamΓ©rica 2015 Initiative: Select results from the first operation me...Salud MesoamΓ©rica 2015 Initiative: Select results from the first operation me...
Salud MesoamΓ©rica 2015 Initiative: Select results from the first operation me...
Β 
Chronic diseases and their risk factors in the Kingdom of Saudi Arabia
Chronic diseases and their risk factors in the Kingdom of Saudi ArabiaChronic diseases and their risk factors in the Kingdom of Saudi Arabia
Chronic diseases and their risk factors in the Kingdom of Saudi Arabia
Β 
Speyer communicating dataforimpact_2015
Speyer communicating dataforimpact_2015Speyer communicating dataforimpact_2015
Speyer communicating dataforimpact_2015
Β 
Understanding the costs of and constraints to health service delivery in Ghana
Understanding the costs of and constraints to health service delivery in GhanaUnderstanding the costs of and constraints to health service delivery in Ghana
Understanding the costs of and constraints to health service delivery in Ghana
Β 
ABCE: Understanding the costs of and constraints to health service delivery ...
ABCE: Understanding the costs of and constraints to health service delivery ...ABCE: Understanding the costs of and constraints to health service delivery ...
ABCE: Understanding the costs of and constraints to health service delivery ...
Β 

Recently uploaded

Merck Moving Beyond Passwords: FIDO Paris Seminar.pptx
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptxMerck Moving Beyond Passwords: FIDO Paris Seminar.pptx
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptxLoriGlavin3
Β 
DSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningDSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningLars Bell
Β 
How AI, OpenAI, and ChatGPT impact business and software.
How AI, OpenAI, and ChatGPT impact business and software.How AI, OpenAI, and ChatGPT impact business and software.
How AI, OpenAI, and ChatGPT impact business and software.Curtis Poe
Β 
WordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your BrandWordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your Brandgvaughan
Β 
Anypoint Exchange: It’s Not Just a Repo!
Anypoint Exchange: It’s Not Just a Repo!Anypoint Exchange: It’s Not Just a Repo!
Anypoint Exchange: It’s Not Just a Repo!Manik S Magar
Β 
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024BookNet Canada
Β 
Search Engine Optimization SEO PDF for 2024.pdf
Search Engine Optimization SEO PDF for 2024.pdfSearch Engine Optimization SEO PDF for 2024.pdf
Search Engine Optimization SEO PDF for 2024.pdfRankYa
Β 
Connect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationConnect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationSlibray Presentation
Β 
Are Multi-Cloud and Serverless Good or Bad?
Are Multi-Cloud and Serverless Good or Bad?Are Multi-Cloud and Serverless Good or Bad?
Are Multi-Cloud and Serverless Good or Bad?Mattias Andersson
Β 
SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024Lorenzo Miniero
Β 
Gen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfGen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfAddepto
Β 
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek SchlawackFwdays
Β 
Unraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdfUnraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdfAlex Barbosa Coqueiro
Β 
Developer Data Modeling Mistakes: From Postgres to NoSQL
Developer Data Modeling Mistakes: From Postgres to NoSQLDeveloper Data Modeling Mistakes: From Postgres to NoSQL
Developer Data Modeling Mistakes: From Postgres to NoSQLScyllaDB
Β 
Dev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio WebDev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio WebUiPathCommunity
Β 
What's New in Teams Calling, Meetings and Devices March 2024
What's New in Teams Calling, Meetings and Devices March 2024What's New in Teams Calling, Meetings and Devices March 2024
What's New in Teams Calling, Meetings and Devices March 2024Stephanie Beckett
Β 
Vertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsVertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsMiki Katsuragi
Β 
Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Scott Keck-Warren
Β 
TrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data PrivacyTrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data PrivacyTrustArc
Β 

Recently uploaded (20)

Merck Moving Beyond Passwords: FIDO Paris Seminar.pptx
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptxMerck Moving Beyond Passwords: FIDO Paris Seminar.pptx
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptx
Β 
DSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine TuningDSPy a system for AI to Write Prompts and Do Fine Tuning
DSPy a system for AI to Write Prompts and Do Fine Tuning
Β 
How AI, OpenAI, and ChatGPT impact business and software.
How AI, OpenAI, and ChatGPT impact business and software.How AI, OpenAI, and ChatGPT impact business and software.
How AI, OpenAI, and ChatGPT impact business and software.
Β 
WordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your BrandWordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your Brand
Β 
Anypoint Exchange: It’s Not Just a Repo!
Anypoint Exchange: It’s Not Just a Repo!Anypoint Exchange: It’s Not Just a Repo!
Anypoint Exchange: It’s Not Just a Repo!
Β 
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024
Β 
Search Engine Optimization SEO PDF for 2024.pdf
Search Engine Optimization SEO PDF for 2024.pdfSearch Engine Optimization SEO PDF for 2024.pdf
Search Engine Optimization SEO PDF for 2024.pdf
Β 
Connect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck PresentationConnect Wave/ connectwave Pitch Deck Presentation
Connect Wave/ connectwave Pitch Deck Presentation
Β 
Are Multi-Cloud and Serverless Good or Bad?
Are Multi-Cloud and Serverless Good or Bad?Are Multi-Cloud and Serverless Good or Bad?
Are Multi-Cloud and Serverless Good or Bad?
Β 
SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024
Β 
Gen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdfGen AI in Business - Global Trends Report 2024.pdf
Gen AI in Business - Global Trends Report 2024.pdf
Β 
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
Β 
Unraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdfUnraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdf
Β 
Developer Data Modeling Mistakes: From Postgres to NoSQL
Developer Data Modeling Mistakes: From Postgres to NoSQLDeveloper Data Modeling Mistakes: From Postgres to NoSQL
Developer Data Modeling Mistakes: From Postgres to NoSQL
Β 
Dev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio WebDev Dives: Streamline document processing with UiPath Studio Web
Dev Dives: Streamline document processing with UiPath Studio Web
Β 
What's New in Teams Calling, Meetings and Devices March 2024
What's New in Teams Calling, Meetings and Devices March 2024What's New in Teams Calling, Meetings and Devices March 2024
What's New in Teams Calling, Meetings and Devices March 2024
Β 
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptxE-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx
Β 
Vertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering TipsVertex AI Gemini Prompt Engineering Tips
Vertex AI Gemini Prompt Engineering Tips
Β 
Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024Advanced Test Driven-Development @ php[tek] 2024
Advanced Test Driven-Development @ php[tek] 2024
Β 
TrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data PrivacyTrustArc Webinar - How to Build Consumer Trust Through Data Privacy
TrustArc Webinar - How to Build Consumer Trust Through Data Privacy
Β 

Meta-regression with DisMod-MR: how robust is the model?

Editor's Notes

  1. Global Burden of Disease Study 2010 (GBD)-huge endeavor to measure health loss from disease, injuries, and risk using the Disability Adjusted Life Year (DALY)-coarsely described in the this 18-step process-I am just going to focus on a small subsection, the calculation of DALYs for injuries and disease-further narrow focus to the calculation of YLDsfigure:Murray, Ezzati, et. al. 2013. β€œGBD 2010: design, definitions, and metrics”. The Lancet. 380(9859):2063-2066.
  2. -YLDsmeasure morbidity, or years lived in less than full health-the YLD calculation needs age-specific prevalence estimates, for GBD, this means ---for 291 outcomes ---for 2 sexes---for 187 countries---for 3 years-however prevalence data is often less than ideal, -examples all available data in Western Europe for GDB2010 Study---sparse (fungal diseases) ---noisy (lower back pain) ---sparse and noisy (cannabis dependence data)-to calculate age-specific prevalence, used a tool called DisMod-MR
  3. -DisMod-MR is designed to address missing data and inconsistency ---used epidemiologic data and covariate data to calculate the age-specific prevalence based on a negative-binomial distribution---assumes all epidemiological data follows a negative-binomial distribution-is it really the best distribution to model the epidemiologic data?figure: Vos, Flaxman, et. al. 2013. β€œYears lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010”. The Lancet. 380(9859):2163-2196.
  4. Normalπœ‡=π‘šπ‘’π‘Žπ‘›πœŽ=π‘ π‘‘π‘Žπ‘›π‘‘π‘Žπ‘Ÿπ‘‘Β π‘‘π‘’π‘£π‘–π‘Žπ‘‘π‘–π‘œπ‘›-mathematically convenient-PROBLEM: allows negative estimates of prevalence, physiological impossibleNegative-binomial𝑁=π‘–π‘›π‘‘π‘–π‘£π‘–π‘‘π‘’π‘Žπ‘™π‘  𝑑𝑒𝑠𝑑𝑒𝑑π‘₯=𝑑𝑒𝑠𝑑𝑒𝑑 π‘π‘œπ‘ π‘–π‘‘π‘–π‘£π‘’π‘=π‘π‘Ÿπ‘œπ‘π‘Žπ‘π‘–π‘™π‘‘π‘¦discrete modeltransformation yields an overdispersion parameter which allows the standard deviation to vary
  5. Lognormalπœ‡=π‘šπ‘’π‘Žπ‘›πœŽ=π‘ π‘‘π‘Žπ‘›π‘‘π‘Žπ‘Ÿπ‘‘Β π‘‘π‘’π‘£π‘–π‘Žπ‘‘π‘–π‘œπ‘›-bounds estimates at 0-PROBLEM: doesn’t allow prevalence to be 0---can’t take the log of 0-changed values of 0 to be 1 observation-other options would be to use an offset lognormal distribution-but somehow, have to work around estimates of 0Negative-binomial𝑁=π‘–π‘›π‘‘π‘–π‘£π‘–π‘‘π‘’π‘Žπ‘™π‘  𝑑𝑒𝑠𝑑𝑒𝑑π‘₯=𝑑𝑒𝑠𝑑𝑒𝑑 π‘π‘œπ‘ π‘–π‘‘π‘–π‘£π‘’π‘=π‘π‘Ÿπ‘œπ‘π‘Žπ‘π‘–π‘™π‘‘π‘¦discrete modeltransformation yields an overdispersion parameter which allows the standard deviation to vary
  6. Binomial-which Dr. Flaxman already discussed-discrete model𝑁=π‘–π‘›π‘‘π‘–π‘£π‘–π‘‘π‘’π‘Žπ‘™π‘ Β π‘‘π‘’π‘ π‘‘π‘’π‘‘π‘₯=π‘‘π‘’π‘ π‘‘π‘’π‘‘Β π‘π‘œπ‘ π‘–π‘‘π‘–π‘£π‘’π‘=π‘π‘Ÿπ‘œπ‘π‘Žπ‘π‘–π‘™π‘‘π‘¦Negative-binomial𝑁=π‘–π‘›π‘‘π‘–π‘£π‘–π‘‘π‘’π‘Žπ‘™π‘  𝑑𝑒𝑠𝑑𝑒𝑑π‘₯=𝑑𝑒𝑠𝑑𝑒𝑑 π‘π‘œπ‘ π‘–π‘‘π‘–π‘£π‘’π‘=π‘π‘Ÿπ‘œπ‘π‘Žπ‘π‘–π‘™π‘‘π‘¦discrete modeltransformation yields an overdispersion parameter which allows the standard deviation to vary
  7. Negative-binomial𝑁=π‘–π‘›π‘‘π‘–π‘£π‘–π‘‘π‘’π‘Žπ‘™π‘ Β π‘‘π‘’π‘ π‘‘π‘’π‘‘π‘₯=π‘‘π‘’π‘ π‘‘π‘’π‘‘Β π‘π‘œπ‘ π‘–π‘‘π‘–π‘£π‘’π‘=π‘π‘Ÿπ‘œπ‘π‘Žπ‘π‘–π‘™π‘‘π‘¦discrete modeltransformation yields an overdispersion parameter which allows the standard deviation to varyNegative-binomial𝑁=π‘–π‘›π‘‘π‘–π‘£π‘–π‘‘π‘’π‘Žπ‘™π‘  𝑑𝑒𝑠𝑑𝑒𝑑π‘₯=𝑑𝑒𝑠𝑑𝑒𝑑 π‘π‘œπ‘ π‘–π‘‘π‘–π‘£π‘’π‘=π‘π‘Ÿπ‘œπ‘π‘Žπ‘π‘–π‘™π‘‘π‘¦discrete modeltransformation yields an overdispersion parameter which allows the standard deviation to vary
  8. Several ways to test which distribution is the best-ideal-data collection---actually go to country (region??) and measure age-specific prevalence---expensiveimpractical-simulation---great for testing, not for validation---problem: have to choose from what distribution the simulated data/measurements come------this is what we’re testing------simulation can showwhatever you want------impossible to know from what distribution measurement-out-of-sample cross validation---way to evaluate and compare distributions---shows how model performs in real life------can test out-of-sample predictive validity------don’t have to choose data distribution---concerns------unstable with sparse data-----------not just the epidemiologic data-----------also covariates and priors
  9. This experiment-57 different disease data sets---met inclusion criteria of more than 4 prevalence points in western europe---not a birth-condition meaning prevalence data is only at age 0-restricted to Western EuropeTo explain out-of-sample cross validation usedan example from GBD2010fungal diseases
  10. Randomly select 25% of data to withhold as test datatest data used to evaluate results
  11. Test data is withheld from DisMod-MR
  12. And the remaining data is fit
  13. From the fit, these estimates are compared to the test dataThis comparison of the estimate to the test data is where the statistics are calculatedthe same test-train split fits are created for each of the distribution so we can make a comparison
  14. -process repeated 1000 times with different test-train splits-repeated for 57 different disease data set---met inclusion criteria of more than 4 prevalence points in western europe---not a birth-condition meaning prevalence data is only at age 057 disease/injury conditions met this criteria
  15. metrics that capture different aspects of model performanceWant a model that is precise, accurate, well-calibrated -precise (bias)---measures average difference between the test data and prediction-accurate (median absolute error-MAE)---measure of overall error---many small errors create one large number---sensitive to mean and scale---less sensitive to outliers-calibrated (percent coverage-PC)---calibrated, meaning that our estimates are in the correct range of values------if we aim for 95% uncertainty, we expect 95% of our estimates to be good------more than that and the model is over confident------less than that and the model isn’t very good---percent of time the uncertainty interval of the prediction contains the observation---sensitive to discrete distributionsto determine which distribution performed the best, counted the the winner for each disease data set and split
  16. -for different metrics different distributions are superior---makes sense, since each distribution has it’s strengths and weaknesses---smallest bias: lognormal---minimum MAE: binomial---closest percent coverage: lognormal-concern about most frequent results and not raw numbers:---differences are small ------bias, ten-thousandths (E-4), average bias is negative binomial------mae, hundreds-overall winner: lognormal
  17. -previously saw, distribution choice doesn’t greatly influence DisMod-MR’s estimates of age-specific prev-results differ by metric-Best overall performance: lognormal distribution---STRESS:Contingent on method to adjust data whose value is 0-Further investigate when each distribution performs best---Dependent on number of covariates, priors, amount of data?DisMod-MR is robust in that choice of distribution for epidemiological values does not greatly influence estimates, but one distribution performs the best most frequently